{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:59:02Z","timestamp":1772189942416,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04683-1","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:23:30Z","timestamp":1769829810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inferior olive lesions in autoimmune glial fibrillary acidic protein astrocytopathy: a report of two cases"],"prefix":"10.1186","volume":"26","author":[{"given":"Haruka","family":"Kuwashige","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Handa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Namiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Shimohata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"4683_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol. 2016;73:1297. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2549.","journal-title":"JAMA Neurol"},{"key":"4683_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol. 2017;81:298\u2013309. https:\/\/doi.org\/10.1002\/ana.24881.","journal-title":"Ann Neurol"},{"key":"4683_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/jnnp-2017-316583","volume":"89","author":"R Iorio","year":"2018","unstructured":"Iorio R, Damato V, Evoli A, Gessi M, Gaudino S, Di Lazzaro V, et al. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients. J Neurol Neurosurg Psychiatry. 2018;89:138\u201346. https:\/\/doi.org\/10.1136\/jnnp-2017-316583.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4683_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/antib13040079","volume":"13","author":"P Gklinos","year":"2024","unstructured":"Gklinos P, Athanasopoulos F, Giatrakou V, Arkoudis N-A, Pournara D, Giagkou E, et al. Unveiling GFAP astrocytopathy: insights from case studies and a comprehensive review of the literature. Antibodies. 2024;13:79. https:\/\/doi.org\/10.3390\/antib13040079.","journal-title":"Antibodies"},{"key":"4683_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jneuroim.2019.04.004","volume":"332","author":"A Kimura","year":"2019","unstructured":"Kimura A, Takekoshi A, Yoshikura N, Hayashi Y, Shimohata T. Clinical characteristics of autoimmune GFAP astrocytopathy. J Neuroimmunol. 2019;332:91\u20138. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.04.004.","journal-title":"J Neuroimmunol"},{"key":"4683_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103512","volume":"58","author":"H Liao","year":"2022","unstructured":"Liao H, Chen Q, Zhang M, Chen W. MRI features and evolution of autoimmune glial fibrillary acidic protein astrocytopathy: a retrospective cross-sectional and longitudinal study. Mult Scler Relat Disord. 2022;58:103512. https:\/\/doi.org\/10.1016\/j.msard.2022.103512.","journal-title":"Mult Scler Relat Disord"},{"key":"4683_CR7","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000013087","volume":"98","author":"A Gravier-Dumonceau","year":"2022","unstructured":"Gravier-Dumonceau A, Ameli R, Rogemond V, Ruiz A, Joubert B, Mu\u00f1iz-Castrillo S, et al. Glial fibrillary acidic protein autoimmunity: a French cohort study. Neurology. 2022;98:668. https:\/\/doi.org\/10.1212\/wnl.0000000000013087.","journal-title":"Neurology"},{"key":"4683_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/brain\/84.3.341","volume":"84","author":"JC Gautier","year":"1961","unstructured":"Gautier JC, Blackwood W. Enlargement of the inferior olivary nucleus in association with lesions of the central tegmental tract or dentate nucleus. Brain. 1961;84:341\u201361. https:\/\/doi.org\/10.1093\/brain\/84.3.341.","journal-title":"Brain"},{"key":"4683_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1001\/archneur.1970.00480200041004","volume":"22","author":"J Lapresle","year":"1970","unstructured":"Lapresle J, Hamida MB. The dentato-olivary pathway: somatotopic relationship between the dentate nucleus and the contralateral inferior Olive. Arch Neurol. 1970;22:135\u201343. https:\/\/doi.org\/10.1001\/archneur.1970.00480200041004.","journal-title":"Arch Neurol"},{"key":"4683_CR10","first-page":"1073","volume":"21","author":"M Goyal","year":"2000","unstructured":"Goyal M, Versnick E, Tuite P, Saint Cyr J, Kucharczyk W, Montanera W, et al. Hypertrophic olivary degeneration: meta-analysis of the Temporal evolution of MR findings. AJNR Am J Neuroradiol. 2000;21:1073\u20137.","journal-title":"AJNR Am J Neuroradiol"},{"key":"4683_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.parkreldis.2016.04.008","volume":"28","author":"T Konno","year":"2016","unstructured":"Konno T, Broderick DF, Tacik P, Caviness JN, Wszolek ZK. Hypertrophic olivary degeneration: a clinico-radiologic study. Parkinsonism Relat Disord. 2016;28:36\u201340. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.04.008.","journal-title":"Parkinsonism Relat Disord"},{"key":"4683_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.brainres.2019.04.024","volume":"1718","author":"H Wang","year":"2019","unstructured":"Wang H, Wang Y, Wang R, Li Y, Wang P, Li J, et al. Hypertrophic olivary degeneration: a comprehensive review focusing on etiology. Brain Res. 2019;1718:53\u201363. https:\/\/doi.org\/10.1016\/j.brainres.2019.04.024.","journal-title":"Brain Res"},{"key":"4683_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000435804","volume":"7","author":"E Franco-Mac\u00edas","year":"2015","unstructured":"Franco-Mac\u00edas E, Rold\u00e1n-Lora F, Mart\u00ednez-Agregado P, Cerd\u00e1-Fuertes N, Moniche F. Neuro-Beh\u00e7et: pons involvement with longitudinal extension to midbrain and hypertrophic olivary degeneration. Case Rep Neurol. 2015;7:148\u201351. https:\/\/doi.org\/10.1159\/000435804.","journal-title":"Case Rep Neurol"},{"key":"4683_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4103\/aian.aian_931_23","volume":"27","author":"AK Datta","year":"2024","unstructured":"Datta AK, Mukherjee A, Biswas A. Post-infective rhombencephalitis with bilateral olivary hypertrophic degeneration. Ann Indian Acad Neurol. 2024;27:210\u20132. https:\/\/doi.org\/10.4103\/aian.aian_931_23.","journal-title":"Ann Indian Acad Neurol"},{"key":"4683_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577003","volume":"334","author":"M Ohara","year":"2019","unstructured":"Ohara M, Sanjo N, Hattori T, Oyama J, Hamada M, Ozaki K, et al. Olivary hypertrophy improved by steroid treatment: two case reports with unique presentations. J Neuroimmunol. 2019;334:577003. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577003.","journal-title":"J Neuroimmunol"},{"key":"4683_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577695","volume":"359","author":"J Equiza","year":"2021","unstructured":"Equiza J, Rodr\u00edguez-Antig\u00fcedad J, Campo-Caballero D, Iruzubieta P, Prada \u00c1, Roncancio A, et al. Autoimmune GFAP astrocytopathy presenting with remarkable CNS hyperexcitability and oculogyric crises. J Neuroimmunol. 2021;359:577695. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577695.","journal-title":"J Neuroimmunol"},{"key":"4683_CR17","unstructured":"The Human Protein Atlas. GFAP in brain. https:\/\/www.proteinatlas.org\/ENSG00000131095-GFAP\/brain. Accessed 28 Sept 2025."},{"key":"4683_CR18","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000200029","volume":"9","author":"B Deng","year":"2022","unstructured":"Deng B, Wang J, Yu H, Jin L, Qiu Y, Liu X, et al. Area postrema syndrome in autoimmune glial fibrillary acidic protein astrocytopathy: a case series and literature review. Neurol Neuroimmunol Neuroinflamm. 2022;9:e200029. https:\/\/doi.org\/10.1212\/nxi.0000000000200029.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"4683_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1366725","volume":"14","author":"J Du","year":"2023","unstructured":"Du J, Cao S, Xia L, Li Q, Tian Y. Corrigendum: plasma exchange for two patients with autoimmune GFAP astrocytopathy with rapid progression to respiratory failure: a case report. Front Immunol. 2023;14:1265609. https:\/\/doi.org\/10.3389\/fimmu.2024.1366725.","journal-title":"Front Immunol"},{"key":"4683_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12883-023-03070-4","volume":"23","author":"PY Wen","year":"2023","unstructured":"Wen PY, Wang GQ, Dou LW, Chen Q, Chen XW, Gong L. A case report of autoimmune GFAP astrocytopathy presenting with abnormal heart rate variability and blood pressure variability. BMC Neurol. 2023;23:24. https:\/\/doi.org\/10.1186\/s12883-023-03070-4.","journal-title":"BMC Neurol"},{"key":"4683_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/17562864231164806","volume":"16","author":"B Deng","year":"2023","unstructured":"Deng B, Wang J, Qiu Y, Liu X, Jin L, Zhu D, et al. Clinical and electrophysiological characteristics of peripheral neuropathy in autoimmune glial fibrillary acidic protein astrocytopathy: an observational study and literature review. Ther Adv Neurol Disord. 2023;16:17562864231164806. https:\/\/doi.org\/10.1177\/17562864231164806.","journal-title":"Ther Adv Neurol Disord"},{"key":"4683_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577233","volume":"343","author":"P Paul","year":"2020","unstructured":"Paul P, McKeon A, Pittock SJ, Klein CJ, Shah S, Toledano M, et al. GFAP IgG associated inflammatory polyneuropathy. J Neuroimmunol. 2020;343:577233. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577233.","journal-title":"J Neuroimmunol"},{"key":"4683_CR23","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1007\/s00415-023-11908-7","volume":"270","author":"J Theuriet","year":"2023","unstructured":"Theuriet J, Cluse F, Gravier-Dumonceau A, Picard G, Closs S, Rogemond V, et al. Peripheral nervous system involvement accompanies central nervous system involvement in anti-glial fibrillary acidic protein (GFAP) antibody-related disease. J Neurol. 2023;270:5545\u201360. https:\/\/doi.org\/10.1007\/s00415-023-11908-7.","journal-title":"J Neurol"},{"key":"4683_CR24","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.braindev.2018.05.009","volume":"40","author":"D Sawada","year":"2018","unstructured":"Sawada D, Fujii K, Misawa S, Shiohama T, Fukuhara T, Fujita M, et al. Bilateral spinal anterior horn lesions in acute motor axonal neuropathy. Brain Dev. 2018;40:830\u20132. https:\/\/doi.org\/10.1016\/j.braindev.2018.05.009.","journal-title":"Brain Dev"},{"key":"4683_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/brain\/120.3.451","volume":"120","author":"H Maier","year":"1997","unstructured":"Maier H, Schmidbauer M, Pfausler B, Schmutzhard E, Budka H. Central nervous system pathology in patients with the Guillain-Barr\u00e9 syndrome. Brain. 1997;120:451\u201364. https:\/\/doi.org\/10.1093\/brain\/120.3.451.","journal-title":"Brain"},{"key":"4683_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00401-003-0768-0","volume":"106","author":"HD M\u00fcller","year":"2003","unstructured":"M\u00fcller HD, Beckmann A, Schr\u00f6der JM. Inflammatory infiltrates in the spinal cord of patients with Guillain-Barr\u00e9 syndrome. Acta Neuropathol. 2003;106:509\u201317. https:\/\/doi.org\/10.1007\/s00401-003-0768-0.","journal-title":"Acta Neuropathol"},{"key":"4683_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S0140-6736(20)32723-9","volume":"397","author":"OC Murphy","year":"2021","unstructured":"Murphy OC, Messacar K, Benson L, Bove R, Carpenter JL, Crawford T, et al. Acute flaccid myelitis: cause, diagnosis, and management. Lancet. 2021;397:334\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(20)32723-9.","journal-title":"Lancet"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04683-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04683-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04683-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:56:17Z","timestamp":1772186177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04683-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4683"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04683-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that the study adhered to the ethical guidelines outlined in the Declaration of Helsinki. For this report, written informed consent was obtained from the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients provided written informed consent for the publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}